American Healthcare REIT, Inc. (NYSE:AHR) Receives Average Recommendation of “Moderate Buy” from Analysts

American Healthcare REIT, Inc. (NYSE:AHRGet Free Report) has received an average recommendation of “Moderate Buy” from the fourteen brokerages that are covering the company, MarketBeat Ratings reports. Three research analysts have rated the stock with a hold rating, ten have given a buy rating and one has given a strong buy rating to the company. The average twelve-month target price among analysts that have updated their coverage on the stock in the last year is $51.6364.

Several equities research analysts recently commented on the company. Citizens Jmp boosted their target price on American Healthcare REIT from $50.00 to $60.00 and gave the stock a “market outperform” rating in a report on Monday, November 10th. JMP Securities lifted their price target on American Healthcare REIT from $45.00 to $50.00 and gave the company a “market outperform” rating in a research report on Friday, October 17th. KeyCorp upped their price objective on American Healthcare REIT from $43.00 to $55.00 and gave the company an “overweight” rating in a report on Thursday, November 13th. Royal Bank Of Canada raised their target price on American Healthcare REIT from $45.00 to $54.00 and gave the company an “outperform” rating in a research note on Wednesday, November 12th. Finally, Jefferies Financial Group reiterated a “buy” rating on shares of American Healthcare REIT in a research report on Monday, December 15th.

Check Out Our Latest Analysis on AHR

Insider Buying and Selling

In related news, Director Jeffrey T. Hanson sold 19,208 shares of the firm’s stock in a transaction that occurred on Tuesday, December 23rd. The shares were sold at an average price of $48.40, for a total transaction of $929,667.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Mark E. Foster sold 1,500 shares of the company’s stock in a transaction on Tuesday, November 11th. The shares were sold at an average price of $49.35, for a total value of $74,025.00. Following the completion of the transaction, the executive vice president directly owned 57,600 shares in the company, valued at $2,842,560. This represents a 2.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 76,288 shares of company stock valued at $3,718,666 over the last 90 days. 0.92% of the stock is currently owned by insiders.

Hedge Funds Weigh In On American Healthcare REIT

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. raised its holdings in American Healthcare REIT by 2.7% during the 3rd quarter. Vanguard Group Inc. now owns 23,529,739 shares of the company’s stock worth $988,484,000 after buying an additional 611,809 shares during the period. State Street Corp increased its position in shares of American Healthcare REIT by 6.5% in the second quarter. State Street Corp now owns 6,902,944 shares of the company’s stock worth $255,289,000 after acquiring an additional 422,931 shares in the last quarter. Invesco Ltd. raised its holdings in shares of American Healthcare REIT by 15.9% during the second quarter. Invesco Ltd. now owns 5,820,530 shares of the company’s stock valued at $213,846,000 after acquiring an additional 798,075 shares during the period. Alliancebernstein L.P. lifted its position in shares of American Healthcare REIT by 16.7% in the 2nd quarter. Alliancebernstein L.P. now owns 5,318,866 shares of the company’s stock valued at $195,415,000 after acquiring an additional 759,501 shares in the last quarter. Finally, Geode Capital Management LLC boosted its stake in American Healthcare REIT by 20.5% in the 2nd quarter. Geode Capital Management LLC now owns 4,578,867 shares of the company’s stock worth $174,882,000 after purchasing an additional 779,109 shares during the period. Institutional investors and hedge funds own 16.68% of the company’s stock.

American Healthcare REIT Trading Up 0.4%

Shares of NYSE:AHR opened at $47.32 on Thursday. The company has a 50 day moving average of $48.28 and a 200-day moving average of $43.16. The company has a current ratio of 0.44, a quick ratio of 0.44 and a debt-to-equity ratio of 0.37. The firm has a market cap of $8.37 billion, a P/E ratio of 338.00, a P/E/G ratio of 1.68 and a beta of 1.02. American Healthcare REIT has a twelve month low of $26.40 and a twelve month high of $51.01.

American Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, January 16th. Investors of record on Wednesday, December 31st will be issued a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 2.1%. The ex-dividend date is Wednesday, December 31st. American Healthcare REIT’s payout ratio is presently 714.29%.

About American Healthcare REIT

(Get Free Report)

American Healthcare REIT, Inc (NYSE: AHR) was a publicly traded real estate investment trust focused on acquiring, owning and managing healthcare‐related properties across the United States. The company’s portfolio spanned senior housing communities, skilled nursing facilities, medical office buildings and outpatient care centers, all operated under long‐term net lease or triple‐net lease structures designed to provide stable, predictable rental income.

Employing a strategy of partnering with established healthcare operators, American Healthcare REIT targeted properties in both major metropolitan areas and high‐growth secondary markets to capitalize on demographic trends such as an aging population and increased demand for outpatient services.

See Also

Analyst Recommendations for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.